UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5488) 5488
Book Chapter (96) 96
Newsletter (19) 19
Book / eBook (18) 18
Dissertation (7) 7
Magazine Article (5) 5
Reference (5) 5
Book Review (2) 2
Conference Proceeding (2) 2
Newspaper Article (2) 2
Report (2) 2
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (4446) 4446
life sciences & biomedicine (4158) 4158
animals (3142) 3142
humans (2373) 2373
male (1908) 1908
cannabinoids (1907) 1907
pharmacology & pharmacy (1829) 1829
neurosciences (1682) 1682
neurosciences & neurology (1630) 1630
rats (1122) 1122
mice (1059) 1059
endocannabinoids (963) 963
biological and medical sciences (960) 960
medical sciences (865) 865
receptor, cannabinoid, cb1 - metabolism (788) 788
psychiatry (777) 777
female (765) 765
marijuana (734) 734
cannabinoids - pharmacology (722) 722
lipids (697) 697
cannabinoid (683) 683
cannabis (681) 681
pyrazoles - pharmacology (586) 586
receptor, cannabinoid, cb1 - antagonists & inhibitors (586) 586
piperidines - pharmacology (568) 568
cannabinoids - therapeutic use (554) 554
analysis (544) 544
disease models, animal (539) 539
dose-response relationship, drug (537) 537
cannabinoid cb1 receptors (524) 524
rodents (515) 515
nervous system (503) 503
biochemistry & molecular biology (488) 488
neurology (462) 462
pain (462) 462
endocannabinoid system (454) 454
anandamide (452) 452
receptor, cannabinoid, cb2 - metabolism (435) 435
receptor, cannabinoid, cb1 - agonists (429) 429
rats, sprague-dawley (425) 425
cannabinoid receptors (423) 423
pharmacology. drug treatments (419) 419
clinical neurology (410) 410
biomedicine (405) 405
research (396) 396
inflammation (389) 389
receptors (388) 388
mice, inbred c57bl (386) 386
health aspects (385) 385
physiological aspects (358) 358
rats, wistar (353) 353
pharmacology (346) 346
brain (337) 337
pharmacology/toxicology (337) 337
adult (335) 335
cell biology (326) 326
care and treatment (325) 325
receptor, cannabinoid, cb2 - agonists (323) 323
arachidonic acids - pharmacology (318) 318
ligands (307) 307
morpholines - pharmacology (305) 305
dronabinol - pharmacology (303) 303
endocannabinoids - metabolism (297) 297
cannabinoid receptor modulators - metabolism (294) 294
proteins (292) 292
medicine (290) 290
tetrahydrocannabinol (284) 284
naphthalenes - pharmacology (277) 277
cannabinoid cb2 receptors (274) 274
enzymes (259) 259
brain - metabolism (254) 254
receptors, cannabinoid - metabolism (245) 245
chemistry (244) 244
cannabidiol (243) 243
multidisciplinary sciences (234) 234
endocannabinoid (233) 233
signal transduction (233) 233
brain - drug effects (230) 230
fatty acids (230) 230
science & technology - other topics (215) 215
drug abuse (212) 212
gene expression (208) 208
mental disorders (208) 208
anxiety (203) 203
physical sciences (203) 203
physiology (202) 202
middle aged (194) 194
neurons (192) 192
neuropharmacology (191) 191
cannabinoid receptor agonists - pharmacology (189) 189
mice, knockout (188) 188
animal models (186) 186
review (185) 185
cannabinoids - metabolism (184) 184
arachidonic acids - metabolism (182) 182
behavior, animal - drug effects (182) 182
phenols (182) 182
receptor, cannabinoid, cb1 - genetics (181) 181
research article (181) 181
obesity (177) 177
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5612) 5612
German (19) 19
French (9) 9
Portuguese (8) 8
Russian (7) 7
Spanish (6) 6
Japanese (5) 5
Hungarian (2) 2
Italian (2) 2
Polish (2) 2
Slovenian (2) 2
Catalan (1) 1
Chinese (1) 1
Czech (1) 1
Dutch (1) 1
Norwegian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuropharmacology, ISSN 0028-3908, 10/2012, Volume 63, Issue 5, pp. 905 - 915
Analgesia | Morphine | Marijuana | G-protein | Adenylyl cyclase | CB1 receptors | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Pyrazoles - therapeutic use | Receptor, Cannabinoid, CB2 - agonists | Humans | Analgesics, Opioid - pharmacology | Receptors, Opioid, mu - agonists | Piperidines - pharmacology | Cannabinoid Receptor Agonists - therapeutic use | Recombinant Proteins - antagonists & inhibitors | Piperidines - metabolism | Receptors, Opioid, mu - metabolism | Morpholines - metabolism | Analgesics, Non-Narcotic - metabolism | Drug Inverse Agonism | Mice | Analgesics, Opioid - metabolism | Kinetics | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Analgesics, Opioid - antagonists & inhibitors | Cannabinoid Receptor Agonists - metabolism | Cricetulus | Analgesics, Non-Narcotic - pharmacology | Cannabinoid Receptor Agonists - pharmacology | Receptor, Cannabinoid, CB2 - genetics | Analgesics, Opioid - adverse effects | Narcotic Antagonists - metabolism | Receptor, Cannabinoid, CB1 - agonists | Analgesics, Non-Narcotic - adverse effects | Cannabinoid Receptor Agonists - adverse effects | Morpholines - adverse effects | CHO Cells | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Binding, Competitive | Recombinant Proteins - metabolism | Cricetinae | Morpholines - pharmacology | Narcotic Antagonists - adverse effects | Recombinant Proteins - agonists | Analgesics, Non-Narcotic - therapeutic use | Pyrazoles - metabolism | Mice, Inbred Strains | Receptors, Opioid, mu - antagonists & inhibitors | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Narcotic Antagonists - therapeutic use | Piperidines - therapeutic use | Narcotic Antagonists - pharmacology | Piperidines - adverse effects | Receptors, Opioid, mu - genetics | Index Medicus | Drugs | Pain perception | Opioid receptors | Cyclic AMP | Opioid receptors (type mu) | Antagonists | Cannabinoid CB1 receptors | Guanine nucleotide-binding protein | Antagonism | Cell activation | Side effects | Inverse agonists | CB1 Receptors | Adenylyl Cyclase
Journal Article
Neuropharmacology, ISSN 0028-3908, 09/2012, Volume 63, Issue 4, pp. 653 - 666
Neuroinflammation | CB2 | CB1 | WIN55212-2 | PPAR-γ | Beta-amyloid | Pharmacology & Pharmacy | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Receptor, Cannabinoid, CB2 - agonists | Neuroglia - pathology | Injections, Intraventricular | Male | PPAR gamma - metabolism | Alzheimer Disease - pathology | Cannabinoid Receptor Agonists - therapeutic use | Neuroglia - immunology | Nootropic Agents - antagonists & inhibitors | Cannabinoid Receptor Antagonists - pharmacology | Neurons - metabolism | Alzheimer Disease - immunology | Morpholines - therapeutic use | Receptors, Cannabinoid - chemistry | Disease Models, Animal | Benzoxazines - administration & dosage | Nerve Tissue Proteins - agonists | Alzheimer Disease - drug therapy | Rats | Hippocampus - pathology | Random Allocation | PPAR gamma - antagonists & inhibitors | Signal Transduction - drug effects | Receptor, Cannabinoid, CB1 - antagonists & inhibitors | Naphthalenes - therapeutic use | Neurons - pathology | Rats, Wistar | Hippocampus - drug effects | Receptor, Cannabinoid, CB2 - antagonists & inhibitors | Cannabinoid Receptor Agonists - chemistry | Neuroglia - drug effects | Receptors, Cannabinoid - metabolism | Anti-Inflammatory Agents, Non-Steroidal - antagonists & inhibitors | Receptor, Cannabinoid, CB1 - agonists | Morpholines - antagonists & inhibitors | Benzoxazines - antagonists & inhibitors | Neurons - drug effects | Nerve Tissue Proteins - antagonists & inhibitors | Hippocampus - immunology | Morpholines - administration & dosage | Neurons - immunology | Nootropic Agents - therapeutic use | Cannabinoid Receptor Agonists - administration & dosage | Benzoxazines - therapeutic use | Nerve Tissue Proteins - metabolism | Hippocampus - metabolism | Receptor, Cannabinoid, CB1 - metabolism | Receptor, Cannabinoid, CB2 - metabolism | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Nootropic Agents - administration & dosage | Naphthalenes - administration & dosage | Alzheimer Disease - metabolism | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | PPAR gamma - agonists | Neuroglia - metabolism | Naphthalenes - antagonists & inhibitors | Index Medicus
Journal Article